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laborators in the San Diego-area Kaiser Permanente System have
achieved the seemingly unachievable e through modest tinkering
with their electronic medical record system, and a prodigious
commitment of imaging resources, they have reduced the number
of unscreened men at risk for early AAA-related death system-wide
by more than 50% within 15 months. This quality improvement
project was undertaken on their own initiative, on the basis of in-
ternal data suggesting an excessive rate of ruptured AAA, with buy-
in from radiologists and other signiﬁcant stakeholders. A truly
remarkable achievement, Bob, for which you are to be rightly
congratulated.
To place this accomplishment in its appropriate context, a few
facets deserve further elaboration by the authors.
First, was it worth it? The manuscript notes that it is too early
to determine whether the incidence of ruptured aneurysm will
decline, or survival improve following emergent repair, as a result
of more comprehensive compliance with screening guidelines.
But, are there sufﬁcient aneurysms in your population to justify
this effort?
The yield of this screening program in this “high-risk” popu-
lation was 1.3%, with only 0.3% of newly identiﬁed AAA > 4.0 cm.
Apparently, there are far fewer AAAs in your population than were
expected at the outset. As noted recently by Frank Lederle, AAA-
related death appears to be in steep decline in the last 20 years,
potentially as a function of declining numbers of cigarettes smoked
per capita by Americans since the 1970s , and it may well be that
current screening guidelines were developed for an “epidemic”
which no longer exists. Also, a recent report from the long-running
Chichester screening study in the UK suggests that as many as 50%
of AAA less than 3.5 cm in diameter do not enlarge further, at least
through 10 years in follow-up. Perhaps the deﬁnition of an AAA as
an aortic diameter greater than 3.0 cm needs to be revised for pur-
poses of preventative screening. To these points, Bob, what is the
prevalence of current vs ever-smokers in your population, and do
you have any insight into trends regarding changes in smoking in-
tensity over time? How would the yield improve if screening were
limited to current or recent smokers or those with a pack/year his-
tory over a certain threshold? What criteria would you use to iden-
tify women at risk, and are plans in place to implement those as
well?
Additionally, what role did other variables play in the observed
prevalence of ruptured AAA? Were there issues with access to care
for some Kaiser subscribers or follow-up of patients already known
or suspected of having AAA?Secondly, your protocol excluded potentially eligible patients
who had received prior abdominal imaging study within the past
10 years, although the results of those prior studies were not
reviewed in the context of this investigation. How was this 10-
year threshold determined? Experience from the UK Small Aneu-
rysm Trial suggests that patients with a sub 3-cm aortic diameter
by age 65 will never go on to develop clinically signiﬁcant AAA dis-
ease, but does that same relationship hold true for younger pa-
tients? What is the risk of later enlargement when the diameter is
3.0 cm or less at age 55, particularly in active smokers?
Did the “best practice alert” system become activated for any
patient visit, for any purpose, to any participating Kaiser facility
(eg, pharmacy visit, or physical therapy appointment, etc)? Now
that you have demonstrated feasibility within Kaiser generally,
what barriers exist to extending this system beyond the San Diego
area (eg, Northern California or Hawaii)?
In summary, committed physicians and professional col-
leagues in the San Diego Kaiser system have demonstrated that,
through the miracle of modern information technology, dramatic
improvements in process measure compliance can be rapidly
achieved. Even though, at the outset, 50% of the at-risk population
were already receiving appropriate care, vast improvement was still
achievable through coordinated effort. Hopefully, this experience
can inform the larger U.S. health system regarding potential
best-practice approaches to guideline compliance. Thank you to
the Program Committee for allowing me to review and discuss
this ﬁne paper, and congratulations again to Dr Hye and his col-
leagues on a remarkable achievement.
Dr Robert J. Hye. I want to thank Dr Dalman for his kind
remarks and review of the manuscript. Before answering the ques-
tions, I want to emphasize that this project involved all of the KP
facilities in Southern California and not just San Diego. Addition-
ally, we did not think our AAA rupture rate was excessive so much
as we felt that many were preventable and part of the mission of
any health care system should be to minimize preventable deaths.
As you correctly point out, the million-dollar question is
whether this screening program is “worth it.” Unfortunately, we
don’t know yet, but our next project will be to determine that.
The current program was implemented largely using existing
personnel, so the major expense was related to the additional ultra-
sound studies. As you know, calculation of all the costs one needs
to consider in the ﬁnancial assessment is complicated.
The other aspect of this question is whether the yield of AAA
is adequate to justify the program. Admittedly, the yield of aneu-
rysms in our study is lower than that of most screening studies.
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versus remote smokers. There is an aggressive smoking cessation
program in KP SCAL and California has one of the lowest rates
of current smokers in the United States, so it is entirely possible
that most of our patients were remote smokers. Additionally, since
one of our selection criteria was the lack of an abdominal imaging
study within the past 10 years, the population selected for
screening probably represents a healthier group in general having
had fewer encounters for medical care. The yield may increase if
we limited screening to recent or current smokers or used a higher
pack-year threshold.
The question of changing the deﬁnition of AAA to a larger
size is interesting. We have had internal discussions regarding
how to manage the population with aortic ectasia and those with
small aneurysms. As you point out, the Chichester study did
show a relatively low rate of aneurysm expansion and suggested
that follow-up scan intervals might be individualized. In the Glou-
cestershire study, although many patients with aortic diameters less
than 3.5 cm did not enlarge in follow-up, 40% of patients with
initial aortic diameters between 3 and 3.9 cm underwent elective
repair within 10 years of screening. A recent meta-analysis also
showed size progression to over 5.4 cm in 26% of patients with
initial aortic diameters of 2.5 to 2.9 cm. I think it would be difﬁcult
to completely exclude patients with aortic diameters between 2.6
and 3.5 cm from follow-up at this point, although applying
some age criteria may be reasonable. We need better data to deter-
mine the appropriate rescreening intervals and whether those inter-
vals should be adjusted on the basis of age, aneurysm growth or
continued smoking.
I am not sure how to identify women at-risk beyond adding
additional factors such as family history or peripheral arterial dis-
ease. Women represented less than 20% of the patients withrupture in our internal review and have a lower prevalence of
AAA, so we do not currently plan to extend screening to females.
We do not believe that access to care was an issue in our prev-
alence of ruptured AAA. The majority of patients who ruptured
had undiagnosed AAA and only a few had had known AAA with
failed follow-up. Our organization does not mandate that patients
have yearly exams, but elderly patients are encouraged to see their
primary care physician regularly, particularly if they have cardiovas-
cular risk factors.
The decision to use 10 years without an abdominal imaging
study as a criteria for screening eligibility was made by consensus
after careful consideration. We recognized that we might miss a
few patients but felt that the yield of AAA in the group with prior
imaging would be low. We also felt that the additional resources
required if we were to review those patients’ studies could not
be justiﬁed. As mentioned in the manuscript, use of Natural Lan-
guage Processing software to review reports may be a way to add
some additional certainty regarding that group.
The “best practice alert” was activated for any physician or
physician extender visit at any KP SCAL facility. An order for a
screening aortic ultrasound is entered by back ofﬁce staff in the
chart of an eligible patient and then signed by the physician. Since
a signed physician order is required, extending the system to non-
provider visits would require a mechanism to generate the order
and obtain a signature. There are no real barriers to implementa-
tion of this system in other Kaiser regions, but Kaiser in Northern
California has generally elected not to use “best practice alerts”.
KP in Hawaii and the Paciﬁc Northwest have screening programs
in place with the latter using the BPA mechanism.
Thank you again for the thoughtful review and we look for-
ward to examining the cost and clinical effectiveness of this pro-
gram for a future presentation.
